- Healthtech startup Kindly has raised $3.5 Mn in the recent funding round.
- Kindly has primarily two verticals–Kindly His and Kindly Hers.
- The company is competing with MediBuddy, MFine, Portea, and Breathe Well-being in the Indian health tech sector.
Healthtech startup Kindly has raised $3.5 Mn in the recent funding round. The funding round saw participation from Y Combinator, DG Daiwa, Olive Tree, Soma, Goodwater, and Gaingels.
The Bengaluru-based startup was founded in 2021 by Nilay Malhotra and Raj Garg. In addition to providing end-to-end sperm health and sexual performance solutions for men, Kindly provides solutions for women suffering from low libido, PCOS, irregular periods, and period pain.
Kindly plans to use these funds to accelerate its growth and expand across domestic and international markets.
Talking about the funding, the cofounder and CEO of Kindly, Nilay Malhotra said, “As a result of the funding, we will transform from a disruptor brand to a leader in lifestyle and sexual wellness. We are poised to enter the next phase of our growth with fresh product lines, a technologically enabled platform, and an intention to expand globally.”
The startup has primarily two verticals–Kindly His and Kindly Hers. Kindly His, deal with sexual performance and sperm health in men. On the other hand, Kindly Hers is concerned with women’s wellness offering products and services for sexual, menstrual, and hormonal problems.
In the future, Startup plans to expand into new categories to address more sexual health and lifestyle issues. According to the statement, it also plans to add 130 million new users and launch a mobile app shortly.
The company is competing with MediBuddy, MFine, Portea, and Breathe Well-being in the Indian health tech sector.
As part of its expansion into non-metro cities of India, MediBuddy has acquired the online consultation platform Clinix. The healthcare and diagnostics company LifeCell International, however, is going to merge with MFine due to its liquidity crisis.
In addition to Portea’s DRHP, Healthvista India also filed its IPO filing with SEBI earlier this month.
The Indian health tech market is expected to reach $5.5 Bn by 2025, growing by 31% from 2021 to 2025, according to a NITI Aayog report.
For More Startup and Funding-related News Visit Alphafirm.